Grosshansdorf is the first Mobilise-D site to reach their target number of participants in the Clinical Validation Study
We are very proud to announce that the Pulmonary Research Institute (PRI) in Grosshandorf, Schleswig-Holstein, Germany, is the first clinical site in our ongoing Clinical Validation Study that has reached their target number of included participants. They just reported that participant #140 has entered the Mobilise-D study, thereby completing their target for the COPD (Chronic…